1Bickel C, Rupprecht HJ, Blankenherg S. Serum uric acid as an independ- ent predieitor of mortality in patients with angiographieany proven coro- nary artery disease [J].Am J cardiol,2002 ;89 : 12.
3Wdowczyk M, Bednarska-Chabowska D, et al. Role of uric acid in cardiovascular diseases[J].Przegl Lek ,2003 ; 160 ( 11 ) :755-7.
4Puddu PE,Lanti M,Menotti A,et al. Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study[J]. Acta Cardiol,2001 ;56(4) :243-51.
5Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid for cardiovascular disease and death: The Framingham heart study[J].Ann Inter Med, 1999 ; 131 ( 1 ) :7213.
8Tatsuno I, Saito Y. Hyperuricemia in hypertension [J]. Nippon Rinsho, 2001 ;59(5 ) :967-72.
9Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure:results from pla- cebocontrolled studies[J]. Circulation ,2002 ; 105 (22) :2619-24.
10Mazzali M, Hughes J, Kin YG, et al. Elevated uric acid increase blood pressure in the rat by a novel crystal-independent mechanism [J]. Hypertension ,2001 ;38 (10) : 1101-6.
3Fischman D, Leon M,Bain D, et al.A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary disease. N Engl J Med, 1994,331:496-501.
4Savage M P, Fischman D L, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent restenosis study[STRESS] investigators. J Am Coll Cardiol, 1998,31:307-311.
5Kastrati S, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997,30:1428-1436.
6Erbel R, Haude M, Hopp H W, et al. Restenosis stent(REST) study: Randomized trial comparing stenting and balloon angioplasty for treatment of restenosis after balloon angioplasty(abstract). J Am Coll Cardiol,1996,27(Suppl A):139-143.
7Barbir M, Hunt B J, Galloway D, et al.A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting. Clin Cardiol, 1994,17:59-65.
8Loscalzo J, Weinfeld M, Fless G M, et al. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis,1990,10:240-245.
9Fang J, Alderman M H. Serum uric acid and cardiovascular mortality. The NHANESI epidemiologic follow-up study, 1971-1992. JAMA, 2000,283:2404-2410.
6Culleton BF,Larson MG,Kannel WB,et al.Serum uric acid and risk for cardiovascular disease and death:the Framingham Heart Study[J].Ann intern Med,1999;131(1):7-13.
7Bickel C,Rupprecht HJ,Blankenberg S,et al.Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J].Am J Cardiol,2002;89(1):12-7.
8Bonora E,Targher G,Zenere MB,et al.Relationship of uric acid concentration cardiovascular risk factors in young man.Role of Atherosclerosis Risk Factors Study[J].Int J Obes Relat Metab Disord,1996;20(11):975-80.
9Rathmann W,Funkhouser E,Dyer AR,et al.Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and White adults:the CARDIA study.Coronary Artery Risk Development in Young Adults[J].Ann Epidemiol,1998;8(4):250-61.
10Leyva F,Anker S,Swan JW,et al.Serum uric acid asan index of impaired oxidative metabolism in chronic heart failure[J].Eur Heart J,1997;18(5):858-65.
